However, paradoxically, a recent study showed that DNGR‐1 limits immune responses to transplantable tumours overexpressing Flt3L, suggesting a context‐dependent role for DNGR‐1 in anti‐cancer immunity beyond cross‐presentation [103]. Here, CLEC9A is linked to cancer.